(2020). ASSESSMENT OF THE ANTI-ANGIOGENIC EFFECT OF IMATINIB ON LARYNGEAL CARCINOMA CELL LINE (HEP2)”. test, 17(1), 179-184. doi: 10.21608/asdj.2020.164434
. "ASSESSMENT OF THE ANTI-ANGIOGENIC EFFECT OF IMATINIB ON LARYNGEAL CARCINOMA CELL LINE (HEP2)”". test, 17, 1, 2020, 179-184. doi: 10.21608/asdj.2020.164434
(2020). 'ASSESSMENT OF THE ANTI-ANGIOGENIC EFFECT OF IMATINIB ON LARYNGEAL CARCINOMA CELL LINE (HEP2)”', test, 17(1), pp. 179-184. doi: 10.21608/asdj.2020.164434
ASSESSMENT OF THE ANTI-ANGIOGENIC EFFECT OF IMATINIB ON LARYNGEAL CARCINOMA CELL LINE (HEP2)”. test, 2020; 17(1): 179-184. doi: 10.21608/asdj.2020.164434

ASSESSMENT OF THE ANTI-ANGIOGENIC EFFECT OF IMATINIB ON LARYNGEAL CARCINOMA CELL LINE (HEP2)”

Ain Shams Dental Journal
Article 24, Volume 17, Issue 1, March 2020, Pages 179-184    PDF (4.4 M)
Document Type: Original articles
DOI: 10.21608/asdj.2020.164434
Statistics
Article View: 112
PDF Download: 204